Q4 2024 · 13F-HR
SB INVESTMENT ADVISERS (UK) LTDholdings as filed
Filed 2025-02-14 · accession 0001493152-25-006623
$11.38B
Reported value
10
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 22266T109 | CPNG | COUPANG INC | $7.68B | 67.5% | 349,542,259 | Common | SOLE |
| G4124C109 | GRAB | GRAB HOLDINGS LIMITED | $1.90B | 16.7% | 401,796,672 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $734.1M | 6.45% | 62,057,537 | Common | SOLE |
| 20464U100 | COMP | COMPASS INC | $339.7M | 2.98% | 58,070,273 | Common | SOLE |
| 35969L108 | YMM | FULL TRUCK ALLIANCE CO LTD | $282.2M | 2.48% | 26,084,929 | Common | SOLE |
| 051774107 | AUR | AURORA INNOVATION INC | $163.8M | 1.44% | 25,997,126 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $122.5M | 1.08% | 16,684,041 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $115.0M | 1.01% | 27,904,963 | Common | SOLE |
| 29280W109 | NRGV | ENERGY VAULT HOLDINGS INC | $42.3M | 0.37% | 18,535,631 | Common | SOLE |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $6.0M | 0.05% | 610,729 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.